The president wants a the most-favored-nation pricing model. But the U.S. drug industry is offering a host of reasons why ...

Industry groups have lined up on opposite sides of Illinois legislation aimed at providing patient access to discount ...

Pharmaceutical stocks, including Pfizer (NYSE: PFE) have recently come under scrutiny following President Trump’s executive order directing drugmakers to lower medicine prices to match what ...

Pharmaceutical stocks, including Pfizer (NYSE: PFE), have recently been scrutinized after President Trump’s executive order instructing drug manufacturers to reduce medicine prices to align with ...

US President Donald Trump signed a broad executive order Monday directing drugmakers to lower the prices of their prescription drugs to align with what other countries pay. Citing figures that ...

The health department has the most authority to change the prices of drugs covered by Medicare and Medicaid because it can set regulations ... Pharma giant Pfizer, which notched $63.6 billion ...

The health department has the most authority to change the prices of drugs covered by Medicare and Medicaid because it can set regulations ... Pharma giant Pfizer, which notched $63.6 billion in ...